IP Library Granted Patent US 12,012,620
Granted Patent B2
US 12,012,620 · App. 17/635,163 · Granted Jun 18, 2024

Peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine

Inventors: Da Duan (Foster City, CA); Auric Anthony Sowell-Kantz (Mill Valley, CA); Aksiniya Lyubenova Petkova (Sunnyvale, CA); Jovana Nazor (Milpitas, CA); Nandhitha Subramanian (Cambridge, GB); Oscar Alvizo (Fremont, CA)
Assignee: Codexis, Inc.
C12N9/0065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,012,620
App. No.
17/635,163
Granted
Jun 18, 2024
Kind
B2
Abstract

The present invention provides engineered peroxidase enzymes, polypeptides having peroxidase activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing peroxidase enzymes are also provided. The present invention further provides compositions comprising the peroxidase enzymes and methods of using the engineered peroxidase enzymes. The present invention finds particular use in the production of pharmaceutical and other compounds.

Claims (12)

1. An engineered peroxidase comprising a polypeptide sequence having, 90%, or more sequence identity to SEQ ID NO: 4, or a functional fragment thereof, wherein said engineered peroxidase comprises a substitution in said polypeptide sequence at position 393, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 4.

2. The engineered peroxidase of claim 1 , wherein said engineered peroxidase further comprises at least one substitution or substitution set at one or more positions in said polypeptide sequence selected from 25/29/43, 25/29/65/82/92, 26/29, 80/128/306, 90, 127/168, 127/301, 128/307, 143, 160, 160/188, 160/307, 164, 168, 171/260, 185, 185/307, 189/190/226, 191, 191/260, 191/469, 202, 206, 208, 221, 222, 224, 224/260, 226, 228, 228/260, 241/270/283/306, 260/307, 290, 301, 306, 307, 311, 332, and 367.

3. The engineered peroxidase of claim 1 , wherein said engineered peroxidase further comprises at least one substitution or substitution set at one or more positions in said polypeptide sequence selected from 26/80/301, 26/160/267/307/329, 26/191, 26/191/202/221/307, 26/191/221, 26/191/307, 26/202/221, 26/221, 26/221/307, 26/301, 26/301/307, 26/307, 80/81/226, 80/202/221/301/307, 80/191, 80/208/306, 90, 90/224, 90/306, 104/168, 104/221, 128/202/221, 168/208, 168/208/224/306, 168/306, 191/221/307, 191, 191/307, 202, 202/221, 208/306, 221, 221/301, 221/307, 226, 301, 301/307, and 307.

4. The engineered peroxidase of claim 1 , wherein said engineered peroxidase comprises a polypeptide sequence that is 90%, or more identical to the sequence of at least one engineered peroxidase variant set forth in SEQ ID NOS: 4 or 6.

5. The engineered peroxidase of claim 1 , wherein said engineered peroxidase is a variant engineered peroxidase set forth in SEQ ID NO: 6.

6. The engineered peroxidase of claim 1 , wherein said engineered peroxidase comprises a polypeptide sequence that is 90%, or more identical to the sequence of at least one engineered peroxidase variant set forth in the even numbered sequences of SEQ ID NOS: 6-290.

7. The engineered peroxidase of claim 1 , wherein said engineered peroxidase comprises a polypeptide sequence set forth in the even numbered sequences of SEQ ID NOS: 6, and 172-290.

8. The engineered peroxidase of claim 1 , wherein said engineered peroxidase comprises at least one improved property compared to wild-type Anabaena ( Nostoc ) sp. Peroxidase, wherein the improved property is increased enzymatic activity on the substrate 10-acetyl-3,7-dihydroxyphenoxazine.

9. The engineered peroxidase of claim 1 , wherein said engineered peroxidase is purified.

10. A composition comprising at least one engineered peroxidase of claim 1 .

11. The engineered peroxidase of claim 1 , wherein the polypeptide sequence of said engineered peroxidase further comprises at least one substitution or substitution set selected from R25A/N29A/H43Y, R25Q/N29A/S65G/F82K/D92G, E80K/E128K/T306F, S90Y, E127K/L301I, E128K/Y307N, E128K/Y307Q, L143H, L143R, I16OH/I188V, I160M, I160V/Y307C, L164D, N168W, T171V/L260R, D185E/Y307H, D185Q, D185T, N191D, N191G, N191S, N191S/L260R, N191S/A469V, F202W, V206L, Q208N, V221H, V221L, V221M, V221P, V221S, V221T, V221Y, N222E, N222S, C224L, C224P, C224R, C224R/L260R, C224Y, K228G, K228M/L260R, E241K/D270N/N283T/T306L, L260R/Y307T, L301S, L301V, T306A, T306V, Y307C, Y307D, Y307E, Y307G, Y307L, Y307M, Y307R, Y307S, P311V, T332A, and A367G.

12. The engineered peroxidase of claim 1 , wherein the polypeptide sequence of said engineered peroxidase further comprises at least one substitution or substitution set selected from N26E/E80K/L301S, N26E/I160V/F267L/Y307M/H329Y, N26E/N191G, N26E/N191S, N26A/N191G, N26A/N191S, N26A/N191S/F202W/V221T/Y307G, N26E/N191G/V221S, N26A/N191G/V221Y, N26E/N191S/Y307E, N26E/N191S/Y307M, N26A/F202W/V221Y, N26A/V221H, N26A/V221S, N26A/V221Y, N26E/V221L, N26E/V221M, N26E/V221Y, N26E/V221H/Y307S, N26E/L301S, N26A/L301S, N26A/L301S/Y307G, N26A/Y307M, N26A/Y307Q, E80K/A81T/F226V, E80K/F202W/V221L/L301S/Y307G, E80K/N191S, E80K/Q208N/T306F, 590Y, S90Y/C224P, S90Y/T306S, S90Y/T306V, S90Y/T306W, Y104D/N168W, Y104H/V221H, E128K/F202W/V2215, N168S/Q208N, N168S/Q208N/C224L/T306V, N168S/T306A, N191D/V221M/Y307G, N191G, N191S, N191S/Y307E, F202L, F202W, F202W/V221H, F202W/V221S, F202W/V221T, Q208N/T306V, V221L/L301S, V221S, V221Y, V221T/Y307E, F226V, L301S, L301S/Y307K, Y307D, Y307L, Y307M, and Y307Q.

Assignments (2)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2024
From: DUAN, DA; SOWELL-KANTZ, AURIC ANTHONY; PETKOVA, AKSINIYA LYUBENOVA; NAZOR, JOVANA; SUBRAMANIAN, NANDHITHA; ALVIZO, OSCAR; DUAN, DA; ALVIZO, OSCAR; SOWELL-KANTZ, AURIC ANTHONY; SUBRAMANIAN, NANDHITHA; PETKOVA, AKSINIYA LYUBENOVA; NAZOR, JOVANA
To: CODEXIS, INC.
Reel/Frame 066421/0399 →
Continuity (2)
Provisional Application 62899190 · Sep 12, 2019
Related Publication 20220290110A1 · Sep 15, 2022
Cited By (1)
US 12,540,314